Precise Bio

Winston-Salem, US · Delaware corporation · 1 known investors

Precise Bio develops a bio-fabrication platform combining tissue engineering, biomaterials, cell technologies, and 4D printing to produce engineered tissues. Its technology targets multiple healthcare fields, including cardiology, orthopedics, and dermatology.

BiotechDeep TechMedical Devices

Founders & leadership

Anthony AtalaDirector, Promoter

Avi KatzExecutive Officer, Director

Shay SokerDirector, Promoter

Aryeh BattExecutive Officer, Director, Promoter

Ilan LiorDirector

Yalon FarhiDirector

Investors · 1

K20 FundValley Stream · $100K – $2.5M

Reported raises · per SEC filings

Form D private placements

▶$12MraisedJan 2024 · 8 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nathan CaliDirector
Viko DanaDirector
Aryeh BattExecutive Officer, Director, Promoter
Shay SokerDirector, Promoter
Dirk MuehlhoffDirector
Ilan LiorDirector
Ori HadimiExecutive Officer, Director
Avi KatzDirector
Anthony AtalaDirector, Promoter

Offering amount: $25M
Amount sold: $12M
Minimum investment: $75K
Sales commissions: $75K
Proceeds to insiders: $700K
Placement agents: Michael Avruch
First sale: Jul 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$15.5MraisedFeb 2022 · 70 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Anthony AtalaDirector, Promoter
Avi KatzExecutive Officer, Director
Shay SokerDirector, Promoter
Aryeh BattExecutive Officer, Director, Promoter
Ilan LiorDirector
Yalon FarhiDirector

Offering amount: $15.5M
Amount sold: $15.5M
Minimum investment: $15K
Sales commissions: $730K
Finders' fees: $557K
Proceeds to insiders: $700K
Placement agents: Nobel Capital
First sale: Nov 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.